I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Motion Sickness
Treatment by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Motion Sickness Treatment by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Motion Sickness
Treatment by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa Markets for Years 2012,
2020 & 2027

Table 4: World Current & Future Analysis for Anticholinergic by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for Anticholinergic by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Anticholinergic by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Antihistamines by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Antihistamines by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Antihistamines by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Other Treatment
Types by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Other Treatment Types by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Other Treatment Types
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Oral by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 14: World Historic Review for Oral by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Oral by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Transdermal by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 17: World Historic Review for Transdermal by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 18: World 15-Year Perspective for Transdermal by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Other Route of
Administrations by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Other Route of
Administrations by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Other Route of
Administrations by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 22: World Current & Future Analysis for Retail Pharmacies
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 23: World Historic Review for Retail Pharmacies by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Retail Pharmacies by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Online Pharmacies
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 26: World Historic Review for Online Pharmacies by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Online Pharmacies by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 28: World Current & Future Analysis for Other
Distribution Channels by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 29: World Historic Review for Other Distribution Channels
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Other Distribution
Channels by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

III. MARKET ANALYSIS

UNITED STATES
Table 31: USA Current & Future Analysis for Motion Sickness
Treatment by Treatment Type - Anticholinergic, Antihistamines
and Other Treatment Types - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 32: USA Historic Review for Motion Sickness Treatment by
Treatment Type - Anticholinergic, Antihistamines and Other
Treatment Types Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 33: USA 15-Year Perspective for Motion Sickness Treatment
by Treatment Type - Percentage Breakdown of Value Sales for
Anticholinergic, Antihistamines and Other Treatment Types for
the Years 2012, 2020 & 2027

Table 34: USA Current & Future Analysis for Motion Sickness
Treatment by Route Of Administration - Oral, Transdermal and
Other Route of Administrations - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 35: USA Historic Review for Motion Sickness Treatment by
Route Of Administration - Oral, Transdermal and Other Route of
Administrations Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 36: USA 15-Year Perspective for Motion Sickness Treatment
by Route Of Administration - Percentage Breakdown of Value
Sales for Oral, Transdermal and Other Route of Administrations
for the Years 2012, 2020 & 2027

Table 37: USA Current & Future Analysis for Motion Sickness
Treatment by Distribution Channel - Retail Pharmacies, Online
Pharmacies and Other Distribution Channels - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 38: USA Historic Review for Motion Sickness Treatment by
Distribution Channel - Retail Pharmacies, Online Pharmacies and
Other Distribution Channels Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 39: USA 15-Year Perspective for Motion Sickness Treatment
by Distribution Channel - Percentage Breakdown of Value Sales
for Retail Pharmacies, Online Pharmacies and Other Distribution
Channels for the Years 2012, 2020 & 2027

CANADA
Table 40: Canada Current & Future Analysis for Motion Sickness
Treatment by Treatment Type - Anticholinergic, Antihistamines
and Other Treatment Types - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 41: Canada Historic Review for Motion Sickness Treatment
by Treatment Type - Anticholinergic, Antihistamines and Other
Treatment Types Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 42: Canada 15-Year Perspective for Motion Sickness
Treatment by Treatment Type - Percentage Breakdown of Value
Sales for Anticholinergic, Antihistamines and Other Treatment
Types for the Years 2012, 2020 & 2027

Table 43: Canada Current & Future Analysis for Motion Sickness
Treatment by Route Of Administration - Oral, Transdermal and
Other Route of Administrations - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 44: Canada Historic Review for Motion Sickness Treatment
by Route Of Administration - Oral, Transdermal and Other Route
of Administrations Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 45: Canada 15-Year Perspective for Motion Sickness
Treatment by Route Of Administration - Percentage Breakdown of
Value Sales for Oral, Transdermal and Other Route of
Administrations for the Years 2012, 2020 & 2027

Table 46: Canada Current & Future Analysis for Motion Sickness
Treatment by Distribution Channel - Retail Pharmacies, Online
Pharmacies and Other Distribution Channels - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 47: Canada Historic Review for Motion Sickness Treatment
by Distribution Channel - Retail Pharmacies, Online Pharmacies
and Other Distribution Channels Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 48: Canada 15-Year Perspective for Motion Sickness
Treatment by Distribution Channel - Percentage Breakdown of
Value Sales for Retail Pharmacies, Online Pharmacies and Other
Distribution Channels for the Years 2012, 2020 & 2027

JAPAN
Table 49: Japan Current & Future Analysis for Motion Sickness
Treatment by Treatment Type - Anticholinergic, Antihistamines
and Other Treatment Types - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 50: Japan Historic Review for Motion Sickness Treatment
by Treatment Type - Anticholinergic, Antihistamines and Other
Treatment Types Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 51: Japan 15-Year Perspective for Motion Sickness
Treatment by Treatment Type - Percentage Breakdown of Value
Sales for Anticholinergic, Antihistamines and Other Treatment
Types for the Years 2012, 2020 & 2027

Table 52: Japan Current & Future Analysis for Motion Sickness
Treatment by Route Of Administration - Oral, Transdermal and
Other Route of Administrations - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 53: Japan Historic Review for Motion Sickness Treatment
by Route Of Administration - Oral, Transdermal and Other Route
of Administrations Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 54: Japan 15-Year Perspective for Motion Sickness
Treatment by Route Of Administration - Percentage Breakdown of
Value Sales for Oral, Transdermal and Other Route of
Administrations for the Years 2012, 2020 & 2027

Table 55: Japan Current & Future Analysis for Motion Sickness
Treatment by Distribution Channel - Retail Pharmacies, Online
Pharmacies and Other Distribution Channels - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 56: Japan Historic Review for Motion Sickness Treatment
by Distribution Channel - Retail Pharmacies, Online Pharmacies
and Other Distribution Channels Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 57: Japan 15-Year Perspective for Motion Sickness
Treatment by Distribution Channel - Percentage Breakdown of
Value Sales for Retail Pharmacies, Online Pharmacies and Other
Distribution Channels for the Years 2012, 2020 & 2027

CHINA
Table 58: China Current & Future Analysis for Motion Sickness
Treatment by Treatment Type - Anticholinergic, Antihistamines
and Other Treatment Types - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 59: China Historic Review for Motion Sickness Treatment
by Treatment Type - Anticholinergic, Antihistamines and Other
Treatment Types Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 60: China 15-Year Perspective for Motion Sickness
Treatment by Treatment Type - Percentage Breakdown of Value
Sales for Anticholinergic, Antihistamines and Other Treatment
Types for the Years 2012, 2020 & 2027

Table 61: China Current & Future Analysis for Motion Sickness
Treatment by Route Of Administration - Oral, Transdermal and
Other Route of Administrations - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 62: China Historic Review for Motion Sickness Treatment
by Route Of Administration - Oral, Transdermal and Other Route
of Administrations Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 63: China 15-Year Perspective for Motion Sickness
Treatment by Route Of Administration - Percentage Breakdown of
Value Sales for Oral, Transdermal and Other Route of
Administrations for the Years 2012, 2020 & 2027

Table 64: China Current & Future Analysis for Motion Sickness
Treatment by Distribution Channel - Retail Pharmacies, Online
Pharmacies and Other Distribution Channels - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 65: China Historic Review for Motion Sickness Treatment
by Distribution Channel - Retail Pharmacies, Online Pharmacies
and Other Distribution Channels Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 66: China 15-Year Perspective for Motion Sickness
Treatment by Distribution Channel - Percentage Breakdown of
Value Sales for Retail Pharmacies, Online Pharmacies and Other
Distribution Channels for the Years 2012, 2020 & 2027

EUROPE
Table 67: Europe Current & Future Analysis for Motion Sickness
Treatment by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 68: Europe Historic Review for Motion Sickness Treatment
by Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 69: Europe 15-Year Perspective for Motion Sickness
Treatment by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets for Years 2012, 2020 & 2027

Table 70: Europe Current & Future Analysis for Motion Sickness
Treatment by Treatment Type - Anticholinergic, Antihistamines
and Other Treatment Types - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 71: Europe Historic Review for Motion Sickness Treatment
by Treatment Type - Anticholinergic, Antihistamines and Other
Treatment Types Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 72: Europe 15-Year Perspective for Motion Sickness
Treatment by Treatment Type - Percentage Breakdown of Value
Sales for Anticholinergic, Antihistamines and Other Treatment
Types for the Years 2012, 2020 & 2027

Table 73: Europe Current & Future Analysis for Motion Sickness
Treatment by Route Of Administration - Oral, Transdermal and
Other Route of Administrations - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 74: Europe Historic Review for Motion Sickness Treatment
by Route Of Administration - Oral, Transdermal and Other Route
of Administrations Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 75: Europe 15-Year Perspective for Motion Sickness
Treatment by Route Of Administration - Percentage Breakdown of
Value Sales for Oral, Transdermal and Other Route of
Administrations for the Years 2012, 2020 & 2027

Table 76: Europe Current & Future Analysis for Motion Sickness
Treatment by Distribution Channel - Retail Pharmacies, Online
Pharmacies and Other Distribution Channels - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 77: Europe Historic Review for Motion Sickness Treatment
by Distribution Channel - Retail Pharmacies, Online Pharmacies
and Other Distribution Channels Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 78: Europe 15-Year Perspective for Motion Sickness
Treatment by Distribution Channel - Percentage Breakdown of
Value Sales for Retail Pharmacies, Online Pharmacies and Other
Distribution Channels for the Years 2012, 2020 & 2027

FRANCE
Table 79: France Current & Future Analysis for Motion Sickness
Treatment by Treatment Type - Anticholinergic, Antihistamines
and Other Treatment Types - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 80: France Historic Review for Motion Sickness Treatment
by Treatment Type - Anticholinergic, Antihistamines and Other
Treatment Types Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 81: France 15-Year Perspective for Motion Sickness
Treatment by Treatment Type - Percentage Breakdown of Value
Sales for Anticholinergic, Antihistamines and Other Treatment
Types for the Years 2012, 2020 & 2027

Table 82: France Current & Future Analysis for Motion Sickness
Treatment by Route Of Administration - Oral, Transdermal and
Other Route of Administrations - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 83: France Historic Review for Motion Sickness Treatment
by Route Of Administration - Oral, Transdermal and Other Route
of Administrations Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 84: France 15-Year Perspective for Motion Sickness
Treatment by Route Of Administration - Percentage Breakdown of
Value Sales for Oral, Transdermal and Other Route of
Administrations for the Years 2012, 2020 & 2027

Table 85: France Current & Future Analysis for Motion Sickness
Treatment by Distribution Channel - Retail Pharmacies, Online
Pharmacies and Other Distribution Channels - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 86: France Historic Review for Motion Sickness Treatment
by Distribution Channel - Retail Pharmacies, Online Pharmacies
and Other Distribution Channels Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 87: France 15-Year Perspective for Motion Sickness
Treatment by Distribution Channel - Percentage Breakdown of
Value Sales for Retail Pharmacies, Online Pharmacies and Other
Distribution Channels for the Years 2012, 2020 & 2027

GERMANY
Table 88: Germany Current & Future Analysis for Motion Sickness
Treatment by Treatment Type - Anticholinergic, Antihistamines
and Other Treatment Types - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 89: Germany Historic Review for Motion Sickness Treatment
by Treatment Type - Anticholinergic, Antihistamines and Other
Treatment Types Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 90: Germany 15-Year Perspective for Motion Sickness
Treatment by Treatment Type - Percentage Breakdown of Value
Sales for Anticholinergic, Antihistamines and Other Treatment
Types for the Years 2012, 2020 & 2027

Table 91: Germany Current & Future Analysis for Motion Sickness
Treatment by Route Of Administration - Oral, Transdermal and
Other Route of Administrations - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 92: Germany Historic Review for Motion Sickness Treatment
by Route Of Administration - Oral, Transdermal and Other Route
of Administrations Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 93: Germany 15-Year Perspective for Motion Sickness
Treatment by Route Of Administration - Percentage Breakdown of
Value Sales for Oral, Transdermal and Other Route of
Administrations for the Years 2012, 2020 & 2027

Table 94: Germany Current & Future Analysis for Motion Sickness
Treatment by Distribution Channel - Retail Pharmacies, Online
Pharmacies and Other Distribution Channels - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 95: Germany Historic Review for Motion Sickness Treatment
by Distribution Channel - Retail Pharmacies, Online Pharmacies
and Other Distribution Channels Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 96: Germany 15-Year Perspective for Motion Sickness
Treatment by Distribution Channel - Percentage Breakdown of
Value Sales for Retail Pharmacies, Online Pharmacies and Other
Distribution Channels for the Years 2012, 2020 & 2027

ITALY
Table 97: Italy Current & Future Analysis for Motion Sickness
Treatment by Treatment Type - Anticholinergic, Antihistamines
and Other Treatment Types - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 98: Italy Historic Review for Motion Sickness Treatment
by Treatment Type - Anticholinergic, Antihistamines and Other
Treatment Types Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 99: Italy 15-Year Perspective for Motion Sickness
Treatment by Treatment Type - Percentage Breakdown of Value
Sales for Anticholinergic, Antihistamines and Other Treatment
Types for the Years 2012, 2020 & 2027

Table 100: Italy Current & Future Analysis for Motion Sickness
Treatment by Route Of Administration - Oral, Transdermal and
Other Route of Administrations - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 101: Italy Historic Review for Motion Sickness Treatment
by Route Of Administration - Oral, Transdermal and Other Route
of Administrations Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 102: Italy 15-Year Perspective for Motion Sickness
Treatment by Route Of Administration - Percentage Breakdown of
Value Sales for Oral, Transdermal and Other Route of
Administrations for the Years 2012, 2020 & 2027

Table 103: Italy Current & Future Analysis for Motion Sickness
Treatment by Distribution Channel - Retail Pharmacies, Online
Pharmacies and Other Distribution Channels - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 104: Italy Historic Review for Motion Sickness Treatment
by Distribution Channel - Retail Pharmacies, Online Pharmacies
and Other Distribution Channels Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 105: Italy 15-Year Perspective for Motion Sickness
Treatment by Distribution Channel - Percentage Breakdown of
Value Sales for Retail Pharmacies, Online Pharmacies and Other
Distribution Channels for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 106: UK Current & Future Analysis for Motion Sickness
Treatment by Treatment Type - Anticholinergic, Antihistamines
and Other Treatment Types - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 107: UK Historic Review for Motion Sickness Treatment by
Treatment Type - Anticholinergic, Antihistamines and Other
Treatment Types Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 108: UK 15-Year Perspective for Motion Sickness Treatment
by Treatment Type - Percentage Breakdown of Value Sales for
Anticholinergic, Antihistamines and Other Treatment Types for
the Years 2012, 2020 & 2027

Table 109: UK Current & Future Analysis for Motion Sickness
Treatment by Route Of Administration - Oral, Transdermal and
Other Route of Administrations - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 110: UK Historic Review for Motion Sickness Treatment by
Route Of Administration - Oral, Transdermal and Other Route of
Administrations Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 111: UK 15-Year Perspective for Motion Sickness Treatment
by Route Of Administration - Percentage Breakdown of Value
Sales for Oral, Transdermal and Other Route of Administrations
for the Years 2012, 2020 & 2027

Table 112: UK Current & Future Analysis for Motion Sickness
Treatment by Distribution Channel - Retail Pharmacies, Online
Pharmacies and Other Distribution Channels - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 113: UK Historic Review for Motion Sickness Treatment by
Distribution Channel - Retail Pharmacies, Online Pharmacies and
Other Distribution Channels Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 114: UK 15-Year Perspective for Motion Sickness Treatment
by Distribution Channel - Percentage Breakdown of Value Sales
for Retail Pharmacies, Online Pharmacies and Other Distribution
Channels for the Years 2012, 2020 & 2027

SPAIN
Table 115: Spain Current & Future Analysis for Motion Sickness
Treatment by Treatment Type - Anticholinergic, Antihistamines
and Other Treatment Types - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 116: Spain Historic Review for Motion Sickness Treatment
by T